- Home
- QNCX vs RDZN Comparison
QNCX vs RDZN Comparison
Compare QNCX & RDZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- RDZN
- Stock Information
- Founded
- QNCX 2012
- RDZN 2015
- Country
- QNCX United States
- RDZN United States
- Employees
- QNCX N/A
- RDZN N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- RDZN Blank Checks
- Sector
- QNCX Health Care
- RDZN Finance
- Exchange
- QNCX Nasdaq
- RDZN Nasdaq
- Market Cap
- QNCX 85.9M
- RDZN 75.2M
- IPO Year
- QNCX 2019
- RDZN N/A
- Fundamental
- Price
- QNCX $1.60
- RDZN $0.96
- Analyst Decision
- QNCX Strong Buy
- RDZN Strong Buy
- Analyst Count
- QNCX 6
- RDZN 2
- Target Price
- QNCX $8.00
- RDZN $5.00
- AVG Volume (30 Days)
- QNCX 124.9K
- RDZN 202.5K
- Earning Date
- QNCX 11-12-2025
- RDZN 11-12-2025
- Dividend Yield
- QNCX N/A
- RDZN N/A
- EPS Growth
- QNCX N/A
- RDZN N/A
- EPS
- QNCX N/A
- RDZN N/A
- Revenue
- QNCX N/A
- RDZN $46,230,126.00
- Revenue This Year
- QNCX N/A
- RDZN $38.45
- Revenue Next Year
- QNCX N/A
- RDZN $66.38
- P/E Ratio
- QNCX N/A
- RDZN N/A
- Revenue Growth
- QNCX N/A
- RDZN N/A
- 52 Week Low
- QNCX $0.69
- RDZN $0.68
- 52 Week High
- QNCX $2.45
- RDZN $2.99
- Technical
- Relative Strength Index (RSI)
- QNCX 47.89
- RDZN 42.09
- Support Level
- QNCX $1.56
- RDZN $0.93
- Resistance Level
- QNCX $1.65
- RDZN $1.00
- Average True Range (ATR)
- QNCX 0.07
- RDZN 0.06
- MACD
- QNCX 0.00
- RDZN 0.00
- Stochastic Oscillator
- QNCX 64.65
- RDZN 34.94
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform auto insurance powered by AI. Its clients comprise insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.